Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
The Economic Times
11,662.6074.25
Stock Analysis, IPO, Mutual Funds, Bonds & More

Hetero launches generic breast cancer treatment drug in India

Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country.

PTI|
Jan 11, 2019, 03.41 PM IST
0Comments
Agencies
Drugs
The tablets are used in combination with Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients, Hetero said.
New Delhi: Drug firm Hetero Friday said it has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country. The tablets, under the brand name 'Hertab', have been launched in the strength of 250 mg, the company said.

The product is marketed and distributed by Hetero Healthcare Ltd and has been made available in two stock keeping units (SKUs), it added.

The tablets are used in combination with Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients, Hetero said.

At present, the company has 36 manufacturing facilities worldwide and has presence in over 126 countries.
0Comments

Also Read

Emcure to launch generic breast cancer medicine

A new AI method may predict future risk of breast cancer

Ladies, check your clock: Being an early riser may lower breast cancer risk

New hope: This common diabetes drug may offer treatment for breast cancer

Oolong tea extracts stop the growth of breast cancer cells

Comments
Add Your Comments
Commenting feature is disabled in your country/region.
Download The Economic Times Business News App for Live Elections News & Results, Latest News in Business, Share Market & More.

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service